Welcome to LookChem.com Sign In|Join Free

CAS

  • or

143390-87-8

Post Buying Request

143390-87-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7H-Furo[3,2-g][1]benzopyran-7-one, 9-[[5-(3,3-dimethyloxiranyl)-3-methyl-2-pentenyl]oxy]-, (E)-

    Cas No: 143390-87-8

  • No Data

  • No Data

  • No Data

  • Kono Chem Co.,Ltd
  • Contact Supplier

143390-87-8 Usage

Description

(E)-9-[[5-(3,3-Dimethyloxiranyl)-3-methyl-2-pentenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one is a complex organic molecule characterized by a unique structure that features a fused furan and benzopyran ring system. (E)-9-[[5-(3,3-Dimethyloxiranyl)-3-methyl-2-pentenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one is notable for its pentenyl and oxiranyl groups, as well as a ketone functional group. The intricate arrangement of these components suggests potential pharmaceutical or biological activity, as similar structures have been linked to anticancer, anti-inflammatory, and antioxidant properties. Further research is necessary to explore the pharmacological potential and safety profile of this compound for possible drug development or other applications.

Uses

Used in Pharmaceutical Industry:
(E)-9-[[5-(3,3-Dimethyloxiranyl)-3-methyl-2-pentenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one is used as a potential candidate for drug development due to its complex chemical structure and the presence of biologically active groups. (E)-9-[[5-(3,3-Dimethyloxiranyl)-3-methyl-2-pentenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one's potential pharmaceutical applications are attributed to the similar properties observed in related structures, such as anticancer, anti-inflammatory, and antioxidant activities.
Used in Research and Development:
In the field of scientific research, (E)-9-[[5-(3,3-Dimethyloxiranyl)-3-methyl-2-pentenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one serves as a valuable subject for exploring the relationship between chemical structure and biological activity. Its unique composition may provide insights into the development of new therapeutic strategies and contribute to the advancement of pharmaceutical sciences.
Used in Chemical Synthesis:
(E)-9-[[5-(3,3-Dimethyloxiranyl)-3-methyl-2-pentenyl]oxy]-7H-furo[3,2-g][1]benzopyran-7-one can be utilized as a key intermediate or building block in the synthesis of more complex molecules with tailored properties. Its unique structure and functional groups make it a promising candidate for the development of novel compounds with specific applications in various industries, including pharmaceuticals, materials science, and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 143390-87-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,3,9 and 0 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 143390-87:
(8*1)+(7*4)+(6*3)+(5*3)+(4*9)+(3*0)+(2*8)+(1*7)=128
128 % 10 = 8
So 143390-87-8 is a valid CAS Registry Number.

143390-87-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 6',7'-Epoxy-8-geranyloxypsoralen

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:143390-87-8 SDS

143390-87-8Upstream product

143390-87-8Relevant articles and documents

Synthesis of 8-geranyloxypsoralen analogues and their evaluation as inhibitors of CYP3A4

Row,Brown,Stachulski,Lennard

, p. 3865 - 3871 (2007/10/03)

Furanocoumarins have been shown to inhibit CYP3A4 in vitro with varying degrees of potency [Pharmacogenetics 1997, 7, 391-396; Chem. Res. Toxicol. 1998, 11, 252-259; Drug Metab. Dispos. 1997, 25, 1228-1233; Br. J. Pharmacol. 2000, 130, 1369-1377]. In this study, we report the effects of a series of novel furanocoumarins based on the naturally occurring derivative 8-geranylepoxypsoralen which has been shown to be a more potent inhibitor of CYP3A4 than its 5-position-substituted counterpart bergamottin [Drug Metab. Dispos. 2000, 28, 766-771; Jpn. J. Pharmacol. 2000, 82, 122-129]. Compounds were designed, synthesised and tested for their ability to inhibit CYP3A4 activity in human liver microsomes using testosterone as the marker substrate. Both the saturated and unsaturated phenolic furanocoumarin derivatives were found to be inactive. However, the 8-alkyloxy-furanocoumarin analogues were shown to inhibit CYP3A4 activity in a dose dependent manner, with IC50 values ranging from 0.78 ± 0.11 to 3.93 ± 0.53 μM. The reduced furan derivative dihydro-8-geranyloxypsoralen showed a 4-fold decrease in inhibitory potency, suggesting that the furan moiety plays a role in the interaction between these compounds and CYP3A4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 143390-87-8